Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

Biomarkers Congress

  • Start Date:
  • 15 Feb 2018
  • Location:
  • Manchester, UK
  • End Date:
  • 16 Feb 2018

Our drug development services team are exhibiting and presenting at the Annual Biomarkers Congress.

Over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 55 presentations, case studies, novel technologies, round-table and panel discussions focused on the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials

6 Interactive Streams:
 
  • Biomarkers in Drug Discovery & Development Therapeutic Areas: Autoimmune, Immuno-oncology, Neuroscience, Oncology
  • Precision Medicine, Companion Diagnostics, Molecular Diagnostics Development
  • Biomarkers in Drug Discovery & Development Therapeutic Areas: Cardiovascular, Rheumatology, Respiratory, COPD, Rare Diseases, Infectious Diseases, Inherited Diseases
  • Innovations in Biomarkers Research, Assay Development, Imaging, Data Integration Methods, Bioinformatics, Trial Design
  • Biomarker: Clinical Development & Clinical Trials
  • Innovative Biology- NGS & Genomic Markers, Clinical Testing and Diagnostics Development

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.


To find out more or to register, please visit: Biomarkers Congress